Avidity Biosciences Company Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Avidity biosciences company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Avidity Biosciences Company Profile Today - Breaking & Trending Today

Arthur A. Levin Sells 40,000 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 40,000 shares of Avidity Biosciences stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $35.07, for a total transaction of $1,402,800.00. Following the completion of the transaction, the director now directly owns […] ....

Los Angeles , United States , Arthura Levin , Los Angeles Capital Management , Proshare Advisors , Cantor Fitzgerald , Avidity Biosciences Company Profile , Avidity Biosciences Inc , Alps Advisors Inc , Board Of Administration Florida Retirement System , Needham Company , Hennion Walsh Asset Management Inc , Securities Exchange Commission , Avidity Biosciences , Get Free Report , Director Arthur , Exchange Commission , Chardan Capital , Florida Retirement System , Angeles Capital Management , Walsh Asset Management , Share Advisors , Alps Advisors , Avidity Biosciences Daily ,

Avidity Biosciences, Inc. (NASDAQ:RNA) CEO Sarah Boyce Sells 28,000 Shares

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 28,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $27.42, for a total value of $767,760.00. Following the completion of the transaction, the chief executive officer now directly […] ....

United States , Sarah Boyce , Vanguard Group Inc , Securities Exchange Commission , Raymond James Financial Services Advisors Inc , Cantor Fitzgerald , Avidity Biosciences Company Profile , Avidity Biosciences Inc , Mirae Asset Global Investments Co , Needham Company , Avidity Biosciences , Get Free Report , Exchange Commission , Capital Partners , James Financial Services Advisors , Asset Global Investments , Chardan Capital , Avidity Biosciences Daily ,

Avidity Biosciences (NASDAQ:RNA) Trading Down 4.3%

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) traded down 4.3% on Tuesday . The stock traded as low as $26.07 and last traded at $26.27. 447,285 shares were traded during mid-day trading, a decline of 60% from the average session volume of 1,124,135 shares. The stock had previously closed at $27.45. Analyst […] ....

United States , Arthura Levin , Quadrant Capital Group , Privium Fund Management , Nisa Investment Advisors , Avidity Biosciences Company Profile , Janney Montgomery Scott , Avidity Biosciences Inc , Cantor Fitzgerald , Needham Company , China Universal Asset Management Co , Avidity Biosciences , Get Free Report , Director Arthur , Investment Advisors , Capital Group , Universal Asset Management , Avidity Biosciences Daily ,

Avidity Biosciences (NASDAQ:RNA) Releases Earnings Results, Beats Expectations By $0.02 EPS

Avidity Biosciences (NASDAQ:RNA – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.79) EPS for the quarter, beating the consensus estimate of ($0.81) by $0.02, Zacks reports. Avidity Biosciences had a negative net margin of 2,103.78% and a negative return on equity of 37.98%. The company had revenue of […] ....

United States , Michaelf Maclean , Sarah Boyce , Avidity Biosciences Inc , Cantor Fitzgerald , Avidity Biosciences Company Profile , Needham Company , Avidity Biosciences , Get Free Report , Avidity Biosciences Daily ,

Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Average Recommendation of "Buy" from Analysts

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the seven brokerages that are presently covering the firm, Marketbeat.com reports. Seven analysts have rated the stock with a buy recommendation. The average 12 month price target among brokers that have updated their coverage on the stock in the […] ....

United States , Arthura Levin , Raymond James Financial Services Advisors Inc , Avidity Biosciences Inc , Securities Exchange Commission , Cantor Fitzgerald , Mirae Asset Global Investments Co , Needham Company , Vanguard Group Inc , Avidity Biosciences Company Profile , Avidity Biosciences , Get Free Report , Chardan Capital , Director Arthur , Exchange Commission , Capital Partners , Asset Global Investments , Raymond James Financial Services Advisors , James Financial Services Advisors , Get Free , Avidity Biosciences Daily , Nasdaq Rna ,